How Your Support Helps Fund Prostate Cancer Research

DonTindallMayo - small

Donald J. Tindall, Ph.D. is the Carl Rosen Professor in Urology, Departments of Urology, Biochemistry Molecular Biology, Mayo Clinic College of Medicine.

“Funding from the T.J. Martell Foundation has been significantly relevant to my research efforts during the past 15 years. This is particularly true over the past 5 years when federal funding has been very scarce. Support from the T.J. Martell Foundation has allowed my laboratory to pursue novel and high risk studies for a better understanding of prostate cancer progression.

Furthermore, this funding has contributed to the professional development of a number of young investigators who are pursuing careers in prostate cancer research. Much of their success can be attributed to funding from the T.J. Martell Foundation. Now, many of these young investigators hold independent research positions as principal investigators at prestigious universities and research institutes. We are grateful for the support of the T.J. Martell Foundation for our efforts to understand the pathobiology of prostate cancer, to define markers for prognosis and to develop novel therapeutics against this devastating disease,” says our funded researcher, Donald Tindall, M.D. of Mayo Clinic.

“The Greatest Reassurance I Can Give to Any Man…”

“We’ve made significant progress in prostate cancer treatments and quality of life for patients over the past five years. My colleagues and I commend the T.J. Martell Foundation for their continued support and appreciate their demonstrated commitment to funding innovative research,” says Mitchell Benson, M.D., Emeritus Chair, Department of Urology, Columbia University Medical Center., who will be receiving our Scientific Achievement Award for Excellence at our New York Golf Classic on July 20th.

Please watch this quick video for an important message from Dr. Benson about prostate cancer.